POMALIDOMIDE: A NOVEL PROMISING IMMUNOMODULATORY AGENT IN THE TREATMENT OF REFRACTORY AND RELAPSED MULTIPLE MYELOMA Journal title: Journal of Drug Discovery and Therapeutics Authors: Ruchika Nandha*| Assistant Professor, Department of Pharmacology, Dr Harvansh Singh Judge Institute... Subject(s): Biomedicine, Anatomy, Pharmacology, Physiology
Postępy w leczeniu szpiczaka mnogiego w roku 2012 Journal title: OncoReview Authors: Artur Jurczyszyn, Anna Engel Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
Progress in treatment of multiple myelomain year 2012 Journal title: OncoReview Authors: Artur Jurczyszyn, Anna Engel Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
Long-lasting Responses to Immunomodulatory Drugs (IMIDs) in Combination with Dexamethasone in Multiple Myeloma; Identification of Exceptional Responders at any Treatment Line Journal title: Haematology International Journal Authors: Marie-Christine Kyrtsonis Subject(s):
In Vitro Effect of Pomalidomide on Bone Marrow Mononuclear Cells From Multiple Myeloma Patients Journal title: Immunoregulation Authors: Shaghayegh Tajik, Mohammadreza Jalali Nadoushan, Jalaledin Shams, Roya Yaraee Subject(s): Medicine, Immunology, Internal Medicine, Health and Wellness
